A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program.

Trial Profile

A Long Term, Multicenter, Non-interventional, Observational Study Monitoring Long-term Safety and Effectiveness of Fingolimod 0.5 mg in Patients With Multiple Sclerosis Who Have Participated in the Fingolimod Clinical Development Program.

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 05 Sep 2012

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Novartis
  • Most Recent Events

    • 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Nov 2011 Planned End Date changed from 1 Feb 2019 to 1 Jan 2019 as reported by ClinicalTrials.gov.
    • 07 Sep 2011 Planned end date changed from 1 Dec 2018 to 1 Feb 2019 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top